• Insights into cancer genomics via COSMIC v98

    Virtual - Americas - EST , United States

    Our understanding of cancer mechanisms, genetics and complexities continues to expand rapidly. Without a streamlined, standardized and easy to understand organizational system to keep track of this plethora of knowledge, […]

  • Target exploration and cell line selection for drug discovery

    Virtual - Americas - EST , United States

    Cancer cell line models have been a cornerstone of cancer research for decades. Profiling cancer cell lines is a powerful tool to identify gene alterations or cancer-related pathways and to […]

  • Metagenomics taxonomic profiling using QIAGEN CLC Genomics Workbench

    Virtual - Americas - EST , United States

    QIAGEN CLC Microbial Genomics Module provides tools and workflows for many various bioinformatics applications, including microbiome analysis, isolate characterization, functional metagenomics and antimicrobial resistance characterization. The module supports the analysis of bacterial, viral and eukaryotic (fungal) genomes and metagenomes. This training focuses on amplicon-based taxonomic profiling (16S/18S/ITS sequencing OTU clustering). Specifically, we’ll cover together: • […]

  • New user training: Large dataset analysis and knowledge base queries using QIAGEN IPA

    Virtual - Americas - EST , United States

    Join us for a 90-minute training session for new users of QIAGEN IPA. In this training, you’ll learn how to: • Upload your dataset (RNA-seq, scRNA-seq, proteomics, metabolomics and more) and perform interactive core/pathway analysis in IPA • Understand the different result types produced (pathways, key regulators, impact on biological functions/diseases and more) • Compare […]

  • Indication expansion and drug repurposing using QIAGEN OmicSoft and Ingenuity Pathway Analysis

    Virtual - Americas - EST , United States

    Research and development for new drugs and disease treatments can be lengthy and costly. Indication expansion can help broaden the impact of a new drug that has already been through the arduous R&D process for a disease or cancer. Drug repurposing can take this concept and expand on it by looking for other diseases with […]

  • Interpreting genetic risk loci from GWAS in the context of key genes and pathways using QIAGEN Ingenuity Pathway Analysis

    Virtual - Americas - EST , United States

    Genome-wide association studies (GWAS) provide insights into the genetic architecture of disease by identifying susceptibility loci for the disease within a population. If you'd like to identify disease genes and novel biological pathways that underlay the disease pathogenesis to identify novel drug targets, QIAGEN Ingenuity Pathway Analysis (IPA) helps you characterize and validate risk loci […]

  • Part I: Single-cell RNA sequencing data analysis using QIAGEN CLC Genomics Workbench

    Virtual - Americas - EST , United States

    This two-part series will walk you through single-cell RNA sequencing (scRNA-seq) analysis starting with a matrix file or FASTQ files and ending with a deep understanding of key pathways, regulators and cell type signatures within your data. This session is for part I of this training. In this session, you'll learn to use QIAGEN CLC […]

  • Part II: Single-cell RNA sequencing data interpretation using QIAGEN Ingenuity Pathway Analysis

    Virtual - Americas - EST , United States

    This two-part series will walk you through single-cell RNA sequencing (scRNA-seq) analysis starting with a matrix file or FASTQ files and ending with a deep understanding of key pathways, regulators and cell type signatures within your data. In this session, we'll explore how you can take your scRNA-seq differential expression results produced from QIAGEN CLC […]